The direct catalytic enantioselective synthesis of protected aryl β-hydroxy-α-amino acids

Angewandte Chemie - International Edition

Volumn 44, Issue 10, 2005, Pages 1543-1545

  Willis, Michael C ^a   Cutting, Gary A ^a   Piccio, Vincent J D ^a   Durbin, Matthew J ^a   John, Matthew P ^b  

^a University of Bath Claverton Down   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Aldol reaction; Amino acids; Asymmetric catalysis; Lewis acids; Magnesium

Indexed keywords

ALDEHYDES; ANTIBIOTICS; CATALYST ACTIVITY; MAGNESIUM PRINTING PLATES; SYNTHESIS (CHEMICAL);

CHIRAL GLYCINE; GLYCOPEPTIDE ANTIBIOTICS; LIGAND;

AMINO ACIDS;

ALPHA AMINO ACID; BETA HYDROXY ALPHA AMINO ACID; BIPHENOMYCIN A; HYDROXYAMINO ACID; RISTOCETIN; UNCLASSIFIED DRUG; VANCOMYCIN;

AMINO ACID METABOLISM; ANALYTIC METHOD; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CATALYSIS; CHEMICAL REACTION; CHIRALITY; DERIVATIZATION; ENANTIOMER; ENANTIOSELECTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IRON TRANSPORT; PROTON NUCLEAR MAGNETIC RESONANCE;

AMINO ACIDS; CATALYSIS; STEREOISOMERISM;

EID: 16244397120     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200462125     Document Type: Article

References (36)

1. Glycopeptide Antiobiotics, (Ed.: R. Nagarajan), Marcel Dekker, New York, 1994.
2. M. Ezaki, M. Iwami, M. Yamashita, S. Hashimoto, T. Komori, K. Umehara, Y. Mine, M. Kohsaka, H. Aoki, H. Imanaka, J. Anlibiot. 1985, 38, 1453.
3. M. K. Renner, Y.-C. Shen, X.-C. Cheng, P. R. Jensen, W. Frankmoelle, C. A. Kauffman, W. E. Fenical, E. Lobkovsky, J. Clardy, J. Am. Chem. Soc. 1999, 121, 11273.
4. R. Barclay, C. Ratledge, J. Bacteriol. 1983, 153, 1138.
5. B. Herbert, I. H. Kim, K. L. Kirk, J. Org. Chem. 2001, 66, 4892.
6. For a discussion of the different approaches used to prepare the β-hydroxy-tyrosine units found in glycopeptide antibiotics, see: K. C. Nicolaou, C. N. C. Boddy, S. Eräse, N. Winssinger, Angew. Chem. 1999, 111, 2230; Angew. Chem. Int. Ed. 1999, 38, 2096.
7. For a discussion of the different approaches used to prepare the β-hydroxy-tyrosine units found in glycopeptide antibiotics, see: K. C. Nicolaou, C. N. C. Boddy, S. Eräse, N. Winssinger, Angew. Chem. 1999, 111, 2230; Angew. Chem. Int. Ed. 1999, 38, 2096.
8. For recent examples, see: a) K. Makino, T. Goto, Y. Hiroki, Y. Hamada, Angew. Chem. 2004, 116, 900; Angew. Chem. Int. Ed. 2004, 43, 882,
9. For recent examples, see: a) K. Makino, T. Goto, Y. Hiroki, Y. Hamada, Angew. Chem. 2004, 116, 900; Angew. Chem. Int. Ed. 2004, 43, 882, for ketone reductions;
10. b) C. Loncaric, W. D. Wulff, Org. Lett. 2001, 3, 3675, for aziridine opening;
11. c) D. L. Boger, M. A. Patane, J. Zhou, J. Am. Chem. Soc. 1994, 116, 8544; for epoxide opening;
12. d) L. Dong, M. J. Miller, J. Org. Chem. 2002, 67, 4759, for dihydroxylation;
13. e) I. H. Kim, K. L. Kirk, Tetrahedron Lett. 2001, 42, 8401, for aminohydroxylation.
14. Selected examples: a) H. Sugiyama, T. Shioiri, F. Yokokawa, Tetrahedron Lett. 2002, 43, 3489;
15. b) J. B. MacMillan, T. F. Molinski, Org. Lett. 2002, 4, 1883;
16. c) S. Caddick, N. J. Parr, M. C. Pritchard, Tetrahedron 2001, 57, 6615;
17. d) M. Horikawa, J. Busch-Peterson, E. J. Corey, Tetrahedron Lett. 1999, 40, 3843;
18. e) S. Kobayashi, H. Ishitani, M. Ueno, J. Am. Chem. Soc. 1998, 120, 431;
19. f) J. Kobayashi, M. Nakamura, Y. Mori, Y. Yamashita, S. Kobayashi, J. Am. Chem. Soc. 2004, 126, 9192.
20. a) Y. Ito, M. Sawamura, T. Hayashi, J. Am. Chem. Soc. 1986, 108, 6405;
21. b) D. A. Evans, J. M. Janey, N. Magomedov, J. S. Tedrow, Angew. Chem. 2001, 113, 1936; Angew. Chem. Int. Ed. 2001, 40, 1884;
22. b) D. A. Evans, J. M. Janey, N. Magomedov, J. S. Tedrow, Angew. Chem. 2001, 113, 1936; Angew. Chem. Int. Ed. 2001, 40, 1884;
23. c) H. Suga, K. Ikai, T. Ibata, J. Org. Chem. 1999, 64, 7040;
24. d) N. Yoshikawa, M. Shibasaki, Tetrahedron 2002, 58, 8289;
25. e) T. Ooi, M. Taniguchi, M. Kameda, K. Maruoka, Angew. Chem. 2002, 114, 4724; Angew. Chem. Int. Ed. 2002, 41, 4542.
26. e) T. Ooi, M. Taniguchi, M. Kameda, K. Maruoka, Angew. Chem. 2002, 114, 4724; Angew. Chem. Int. Ed. 2002, 41, 4542.
27. M. C. Willis, V. J.-D. Piccio, Synlett 2002, 1625.
28. Oxazolidinone 3 was prepared from the corresponding azide, according to the procedure reported for a chiral derivative in Reference [12a]. See Supporting Information for details.
29. For examples of the use of a chiral version of 3 in diastereoselective aldol additions, see: a) D. A. Evans, A. E. Weber, J. Am. Chem. Soc. 1986, 108, 6757;
30. b) D. A. Evans, A. E. Weber, J. Am. Chem. Soc. 1987, 109, 7151;
31. c) M. A. Lago, J. Samanen, J. D. Elliot, J. Org. Chem. 1992, 57, 3493;
32. d) D. L. Boger, S. L. Colletti, T. Honda, R. F. Menezes, J. Am. Chem. Soc. 1994, 116, 5607. See also Reference [5].
33. For the use of a Mg-bis(oxazoline) catalyst system in the direct enantioselective addition of malonate derivatives to nitroalkenes, see: J. Ji, D.M. Barnes, J. Zhang, S. A. King, S. J. Wittenberger, H. E. Morton, J. Am. Chem. Soc. 1999, 121, 10215.
34. The addition of 20 mol % water to the reaction resulted in a significant reduction in the enantioselectivity of the process (50-60% ee depending on the exact reaction).
35. The absolute configuration of the benzaldehyde adduct (Table 2, entry 1) was established by X-ray crystallography; the remaining adducts are assigned by analogy.
36. N. J. Skelton, D. H. Williams, M. J. Rance, J. C. Ruddock, J. Chem. Soc. Perkin Trans, 1 1990, 77.